FrancophonIA/ELRC3.0 huggingface dataset:
English: Amber molded glass type 1 vial, 20 ml, chlorobutyl rubber stopper and aluminium overseal with flip-off button.
Slovenian: 20 ml steklena viala, steklo tipa I, jantarjeve barve, zaprta s klorobutilnim gumijastim zamaškom in aluminijastim pokrovčkom z zaporko.
English: The tablets have a score line allowing the tablet to be halved, with the letters “MPT” and figures denoting the quantity of maropitant on one side, the reverse side is blank.
Slovenian: s Črke 'MPT' in številke, ki označujejo količino maropitanta so na eni strani.
English: Maropitant is metabolised in the liver and therefore should be used with caution in dogs and cats with liver disease.
Slovenian: Maropitant se metabolizira v jetrih, zato je potrebna previdna uporaba pri psih in mačkah z jetrnimi obolenji.
English: Maropitant displays linear kinetics when administered subcutaneously within the 0.5-2 mg/kg dose range.
Slovenian: Maropitant kaže linearno kinetiko po subkutanem dajanju v odmerku 0,5 - 2 mg/kg.
English: STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENTS
Slovenian: NAVEDBA ZDRAVILNE UČINKOVIN(E) IN DRUGE(IH) SESTAVIN(E)
English: Peak concentrations were followed by a decline in systemic exposure with an apparent elimination half-life (t0.5) of 4.03 hours.
Slovenian: Vrhu koncentracije sledi upadanje sistemske izpostavitve s polovičnim časom izločitve (t1/2) 4,03 ure.
English: Maropitant is a potent and selective neurokinin (NK-1) receptor antagonist, which acts by inhibiting the binding of substance P, a neuropeptide of the tachykinin family, in the CNS.
Slovenian: Maropitant je močan in selektiven antagonist neurokinin receptorja (NK-1), ki inhibira vezavo substance P, tahikininski neuropeptid, v centralnem živčnem sistemu.
English: Cerenia can be used to treat or prevent vomiting either as tablets or as solution for injection administered once daily.
Slovenian: Cerenia se uporablja za zdravljenje ali preprečevanje bruhanja v obliki tablet ali raztopine za injiciranje enkrat dnevno.
English: To prevent vomiting induced by motion sickness, Cerenia tablets should be administered once daily, at a dose of 8 mg maropitant per kg bodyweight, using the numbers of tablets given in the table below.
Slovenian: Za preprečevanje bruhanja, ki je posledica slabosti zaradi vožnje, dajemo Cerenia tablete enkrat dnevno v odmerku 8 mg maropitanta na kg telesne mase, uporabimo število tablet, kot je navedeno v tabeli.
English: Maropitant is metabolised in the liver and therefore should be used with caution in patients with hepatic disease.
Slovenian: Maropitant se metabolizira v jetrih, zato je potrebna previdna uporaba pri bolnikih z jetrnimi obolenji.
English: Name and address of the manufacturers responsible for batch release
Slovenian: Ime in naslov izdelovalca zdravila, odgovornega za sproščanje serije
English: To treat and/or prevent vomiting except motion sickness, Cerenia tablets should be administered once daily, at a dose of 2 mg maropitant per kg bodyweight, using the number of tablets given in the table below.
Slovenian: Za zdravljenje ter/ali preprečevanje bruhanja (razen slabosti zaradi vožnje) dajemo tablete Cerenia enkrat dnevno v odmerku 2 mg maropitanta na kg telesne mase, uporabimo število tablet, kot je navedeno v tabeli.
English: Renal clearance is a minor route of elimination, with less than 1% of an 8 mg/kg oral dose appearing in the urine as either maropitant or its major metabolite.
Slovenian: Ledvični klirens predstavlja manjši delež izločitve, saj se manj kot 1 % peroralnega odmerka 8 mg/kg izloči z urinom kot maropitant ali njegov metabolit.
English: Detailed information on this veterinary medicinal product is available on the website of the European Medicines Agency (http://www.ema.europa.eu/).
Slovenian: Podrobne informacije o tem zdravilu za uporabo v veterinarski medicini so na voljo na spletni strani
English: People with known hypersensitivity to maropitant should administer the veterinary medicinal product with caution.
Slovenian: Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo Osebe z znano preobčutljivostjo na maropitant naj zdravilo dajejo previdno.
English: Renal clearance is a minor route of elimination, with less than 1% of a 1 mg/kg subcutaneous dose appearing in the urine as either maropitant or its major metabolite.
Slovenian: Ledvični klirens predstavlja manjši delež izločanja, saj se manj kot 1 % subkutanega odmerka 1 mg/kg izloči z urinom kot maropitant ali njegov glavni presnovek.
English: Following repeated oral administration for five consecutive days at a daily dose of 2 mg/kg, accumulation was 151%.
Slovenian: Pri ponavljajočem se peroralnem dajanju 5 zaporednih dni, dnevni odmerek 2 mg/kg, je akumulacija 151 %.
English: In dogs, Cerenia can be used to treat or prevent vomiting either as tablets or as solution for injection administered once daily.
Slovenian: Pri psih se Cerenia za zdravljenje ali preprečevanje bruhanja lahko uporablja v obliki tablet ali raztopine za injiciranje enkrat dnevno.
English: The solution for injection contains 10 mg maropitant per ml as maropitant citrate monohydrate as a clear, colourless to light yellow solution.
Slovenian: 1 ml raztopine za injiciranje vsebuje 10 mg maropitanta v obliki maropitantijevega citrata monohidrata, v obliki prozorne, brezbarvne do rahlo rumene raztopine.
English: In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician.
Slovenian: V primeru nenamernega zaužitja se takoj posvetujte z zdravnikom in mu pokažite navodila za uporabo ali nalepko na zunanji ovojnini.
English: For the prevention of nausea induced by chemotherapy and treatment and prevention of vomiting (except motion sickness), (only for dogs 8 weeks of age or older).
Slovenian: Preprečevanje slabosti povzročene zaradi kemoterapije ter zdravljenje in preprečevanje bruhanja (razen slabosti zaradi vožnje) (samo za pse, stare 8 tednov in več)
English: Estimates for the oral bioavailability of maropitant were 23.7% at 2 mg/kg and 37.0% at 8 mg/kg.
Slovenian: Ocena peroralne biorazpoložljivosti maropitanta je 23,7 % pri 2 mg/kg in 37,0 % pri 8 mg/kg.Volumen distribucije v fazi stabilizacije koncentracije (VSS), določen po intravenskem vnosu 1 - 2 mg/kg je od približno 4,4 do 7,0 l/kg.
English: A variety of in vitro assays have demonstrated that maropitant binds selectively at the NK1 receptor with dose-dependent functional antagonism of substance P activity.
Slovenian: Več in vitro poskusov je dokazalo, da se maropitant selektivno veže na NK1 receptor.
English: To treat or prevent vomiting, Cerenia tablets should be administered once daily, at a dose of 2 mg maropitant per kg bodyweight, using the number of tablets given in the table below.
Slovenian: Za zdravljenje ali preprečevanje bruhanja dajemo tablete Cerenia enkrat dnevno v odmerku 2 mg maropitanta na kg telesne mase, uporabimo število tablet, kot je navedeno v tabeli.
English: FAREVA AMBOISE Zone Industrielle, 29 route des Industries 37530 Pocé-sur-Cisse FRANCE
Slovenian: FAREVA AMBOISE Zone Industrielle, 29 route des Industries
English: • For the prevention of nausea induced by chemotherapy.
Slovenian: • Za preprečevanje slabosti, povzročene s kemoterapijo.
English: Sulphobutyl ether β-cyclodextrin (SBECD) Metacresol
Slovenian: FARMACEVTSKI PODATKI 6.1 Seznam pomožnih snovi Sulfobutil eter β-ciklodekstrin (SBECD)
English: A. MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE
Slovenian: A. IMETNIK DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVOREN ZA SPROSTITEV SERIJE
English: Cerenia 10 mg/ml injection for dogs and cats maropitant
Slovenian: Cerenia 10 mg/ml raztopina za injiciranje za pse in mačke maropitant
English: Maropitant is metabolised in the liver and therefore should be used with caution in dogs with liver disease.
Slovenian: Maropitant se metabolizira v jetrih, zato je potrebna previdna uporaba pri psih z jetrnimi obolenji.
English: The pharmacokinetic profile of maropitant when administered as a single subcutaneous dose of 1 mg/kg body weight to dogs was characterised by a maximum concentration (Cmax) in plasma of approximately 92 ng/ml; this was achieved within 0.75 hours post-dosing (Tmax).
Slovenian: Za farmakokinetični profil maropitanta, danega psom v enkratnem subkutanem odmerku 1 mg/kg telesne mase, je značilna najvišja koncentracija (Cmax) v plazmi okoli 92 ng/ml; ta je dosežena v 0,75 ure po dajanju (tmax).
English: The pharmacokinetic profile of maropitant when administered as a single oral dose of 2 mg/kg body weight to dogs was characterised by a maximum concentration (Cmax) in plasma of approximately 81 ng/ml; this was achieved within 1.9 hours post-dosing (Tmax).
Slovenian: Za farmakokinetični profil maropitanta, danega psom v enkratnem peroralnem odmerku 2 mg/kg telesne mase, je značilna najvišja koncentracija (Cmax) v plazmi okoli 81 ng/ml; ta je dosežena v 1,9 ure po dajanju (Tmax).
English: EU/2/06/062/005
Slovenian: ŠTEVILKA(E) DOVOLJENJ(A) ZA PROMET EU/2/06/062/005
English: Shelf life after first opening the immediate packaging: 28 days.
Slovenian: Rok uporabnosti zdravila v pakiranju za prodajo: 3 leta Rok uporabnosti po prvem odpiranju stične ovojnine: 28 dni.
English: The pharmacokinetic profile of maropitant when administered as a single subcutaneous dose of 1 mg/kg body weight to cats was characterised by a maximum concentration (Cmax) in plasma of approximately 165 ng/ml; this was achieved on average 0.32 hours (19 min) post-dosing (Tmax).
Slovenian: Za farmakokinetični profil maropitanta, danega mačkam v enkratnem subkutanem odmerku 1 mg/kg telesne mase, je značilna najvišja koncentracija (Cmax) v plazmi okoli 165 ng/ml; ta je dosežena v 0,32 ure po dajanju (tmax).
English: The safety of the veterinary medicinal product has not been established in dogs less than 16 weeks of age for the 8 mg/kg dose (motion sickness), and in dogs less than 8 weeks of age for the 2 mg/kg dose (vomiting) as well as in pregnant or lactating bitches.
Slovenian: Varnost zdravila v odmerku 8 mg/kg (slabost med vožnjo) pri psih, mlajših od 16 tednov, v odmerku 2 mg/kg (bruhanje) pri psih, mlajših od 8 tednov, ter pri psicah v obdobju brejosti in laktacije ni bila dokazana.
English: Incidents of pre-travel vomiting, usually within two hours post-dosing were commonly reported after administration of the 8 mg/kg dose.
Slovenian: Po dajanju odmerka 8 mg/kg se je lahko pred vožnjo pojavilo bruhanje, ponavadi v dveh urah po dajanju.
English: NAME OF MARKETING AUTHORISATION HOLDER
Slovenian: IME IMETNIKA DOVOLJENJA ZA PROMET Z ZDRAVILOM
English: Maropitant (as maropitant citrate monohydrate)
Slovenian: Zdravilna učinkovina: Maropitant (v obliki maropitantijevega citrata monohidrata) 10 mg.
English: Cerenia 10 mg/ml solution for injection for dogs and cats
Slovenian: Cerenia 10 mg/ml raztopina za injiciranje za pse in mačke
English: Zoetis (Logo)
Slovenian: Zoetis
English: The safety of the veterinary medicinal product has not been established in dogs less than 8 weeks of age, or in cats less than 16 weeks of age, and in pregnant or lactating dogs and cats.
Slovenian: Varnost zdravila pri psih, mlajših od 8 tednov, pri mačkah, mlajših od 16 tednov, ter pri psicah in mačkah v obdobju brejosti in laktacije ni bila dokazana.
English: Prevention of motion sickness
Slovenian: Preprečevanje slabosti zaradi vožnje
English: • For the prevention of vomiting and the reduction of nausea, except that induced by motion sickness.
Slovenian: • Za preprečevanje bruhanja, razen bruhanja, ki je posledica slabosti zaradi vožnje.
English: • For the prevention of vomiting except that induced by motion sickness.
Slovenian: • Za preprečevanje bruhanja razen bruhanja, ki je posledica vožnje
English: Giving your dog a light meal or snack before administering the tablet could help preventing this effect.
Slovenian: Ta učinek lahko preprečite tako, da psu ponudite manjši obrok ali prigrizek pred aplikacijo tablete.
English: Prevention of nausea induced by chemotherapy Treatment and prevention of vomiting (except motion sickness) Dog body weight (kg)
Slovenian: Preprečevanje slabosti povzročene s kemoterapijo Zdravljenje ter preprečevanje bruhanja (razen slabosti zaradi vožnje)
English: Apart from transient reactions at the injection site following subcutaneous administration, Cerenia solution for injection was well tolerated in dogs and young cats injected daily with up to 5 mg/kg (5
Slovenian: Z izjemo prehodnih reakcij na mestu injiciranja po subkutanem dajanju, so injiciranje odmerka do 5
English: AUTHORISATION
Slovenian: FRANCIJA
English: PACKAGE LEAFLET: Cerenia 10 mg/ml solution for injection for dogs and cats
Slovenian: NAVODILO ZA UPORABO Cerenia 10 mg/ml raztopina za injiciranje za pse in mačke
English: The safety of Cerenia has not been established in dogs less than 8 weeks of age, or in cats less than 16 weeks of age, and in pregnant or lactating dogs and cats.
Slovenian: Varnost zdravila Cerenia pri psih, mlajših od 8 tednov, mačkah, mlajših od 16 tednov ter pri psicah in mačkah v obdobju brejosti in laktacije ni bila dokazana.
English: The responsible veterinarian should make a benefit-risk assessment before using Cerenia in dogs under 8 or 16 weeks of age, respectively, or in pregnant or lactating bitches.
Slovenian: Pred uporabo zdravila Cerenia pri psih, mlajših od 8 oziroma 16 tednov ali pri psicah v obdobju brejosti in laktacije, mora odgovorni veterinar oceniti razmerje korist/tveganje.
English: As maropitant is accumulated in the body during a 14-day treatment period due to metabolic saturation, careful monitoring of liver function in addition to any adverse events should be implemented during long term treatment.
Slovenian: Med dolgotrajnim zdravljenjem je treba skrbno spremljati delovanje jeter in in druge neželene učinke, ker se maropitant zaradi saturacije presnove med 14 dnevnim zdravljenjem, kopiči v telesu.
English: times the recommended dose) for 15 consecutive days (3-times the recommended duration of administration).
Slovenian: mg/kg (5x večji odmerek od priporočenega) 15 zaporednih dni (3x daljše obdobje od priporočenega) psi in mlade mačke dobro prenašali.
English: Each tablet contains 24 mg maropitant as maropitant citrate monohydrate.
Slovenian: Tableta vsebuje 24 mg maropitanta v obliki maropitantijevega citrata monohidrata.
English: The effect duration is approximately 24 h and therefore treatment can be given the night before administration of an agent that may cause emesis e.g. chemotherapy.
Slovenian: Učinek traja približno 24 ur, zato lahko zdravilo damo večer pred dajanjem zdravila, ki bi lahko povzročilo slabost,
English: Clinical signs including vomiting on first administration, excess salivation and watery faeces have been observed when the product has been overdosed in excess of 20 mg/kg.
Slovenian: Po dajanju odmerka, ki je presegel 20 mg/kg, so opazili klinične znake, kot so bruhanje po prvem dajanju, prekomerno slinjenje in vodeno blato.
English: Each tablet contains 16 mg maropitant as maropitant citrate monohydrate.
Slovenian: Tableta vsebuje 16 mg maropitanta v obliki maropitantijevega citrata monohidrata.
English: Each tablet contains 60 mg maropitant as maropitant citrate monohydrate.
Slovenian: Tableta vsebuje 60 mg maropitanta v obliki maropitantijevega citrata monohidrata.
English: Each tablet contains 160 mg maropitant as maropitant citrate monohydrate.
Slovenian: Tableta vsebuje 160 mg maropitanta v obliki maropitantijevega citrata monohidrata.
English: The volume of distribution at steady-state (Vss) was 9.3 l/kg and systemic clearance was 1.5 l/h/kg.
Slovenian: l/kg in sistemski očistek je bil 1,5 l/h/kg.
English: • For the prevention of vomiting induced by motion sickness.
Slovenian: • Za preprečevanje bruhanja, ki je posledica slabosti zaradi vožnje.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER / Tablets
Slovenian: PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU ALI DVOJNEM TRAKU
English: Further information on ProZinc can be found on the Agency's website: ema.europe.eu/medicines/veterinary/EPAR/prozinc
Slovenian: Nadaljnje informacije o zdravilu ProZinc so na voljo na spletni strani agencije: ema.europe.eu/medicines/veterinary/EPAR/prozinc
English: ProZinc (human insulin)
Slovenian: ProZinc (humani insulin)
English: It is given as an injection under the skin twice daily for cats and once daily for dogs either at the same time or immediately after a meal.
Slovenian: Daje se kot injekcija pod kožo dvakrat na dan pri mačkah in enkrat na dan pri psih hkrati z obrokom ali takoj po njem.
English: There is a low chance of an allergic reaction in sensitised people.
Slovenian: Pri preobčutljivih ljudeh obstaja majhna verjetnost za alergijsko reakcijo.
English: It contains the active substance human insulin.
Slovenian: Vsebuje učinkovino humani insulin.
English: These hypoglycaemic events are generally mild in nature.
Slovenian: Hipoglikemični dogodki so na splošno blagi.
English: After 12 weeks, 113 out of 134 ProZinc treated dogs (84%) were successfully treated, compared to 91 out of the 111 control dogs (82%).
Slovenian: Po 12 tednih je bilo uspešno zdravljenih 113 od 134 (84 %) psov, v primerjavi z 91 od 111 (82 %) psov v kontrolni skupini.
English: The correct dose is determined individually for each animal depending on weight and needs to be adjusted depending on the response to treatment.
Slovenian: Pravilen odmerek se določi za vsako žival posebej, odvisno od njene telesne mase, in ga je treba prilagoditi glede na odziv na zdravljenje.
English: ProZinc received a marketing authorisation valid throughout the EU on 12 July 2013.
Slovenian: Zdravilo ProZinc je pridobilo dovoljenje za promet, veljavno po vsej Evropski uniji, 12. julija 2013.
English: The European Medicines Agency decided ProZinc's benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zaključila, da so koristi zdravila ProZinc večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: ProZinc (human insulin) EMA/300817/2013
Slovenian: ProZinc (humani insulin) EMA/300817/2013
English: Other information about ProZinc
Slovenian: Druge informacije o zdravilu ProZinc
English: Because of its prolonged action, it must also not be used for the short-term management of diabetic ketoacidosis (a serious complication of diabetes with high levels of ketones in the blood).
Slovenian: Zaradi svojega podaljšanega delovanja se tudi ne sme uporabljati za kratkoročno upravljanje diabetične ketoacidoze (resnega zapleta pri sladkorni bolezni z visoko vsebnostjo ketonov v krvi).
English: These are absorbed more slowly after injection and take longer to reach their target in the body than naturally produced insulin.
Slovenian: Ti se po injiciranju absorbirajo počasneje in traja dlje, da dosežejo svoj cilj v telesu kot naravno tvorjeni insulin.
English: Why is ProZinc authorised in the EU?
Slovenian: Zakaj je bilo zdravilo ProZinc odobreno v EU?
English: ProZinc must not be used in cats or dogs which are hypersensitive (allergic) to insulin or any of the other ingredients.
Slovenian: Zdravilo ProZinc se ne sme uporabljati pri mačkah in psih, ki so preobčutljivi za (alergični na) insulin ali katero koli drugo sestavino zdravila.
English: What is ProZinc and what is it used for?
Slovenian: Kaj je zdravilo ProZinc in za kaj se uporablja?
English: An overview of ProZinc and why it is authorised in the EU
Slovenian: Pregled zdravila ProZinc in zakaj je odobreno v EU
English: What are the risks associated with ProZinc?
Slovenian: Kakšna tveganja so povezana z zdravilom ProZinc?
English: This results in increased blood glucose levels and associated clinical signs such as polyuria (increase in urine volume), polydipsia (increase in water intake) and weight loss.
Slovenian: Posledica so povečane ravni glukoze v krvi in z njimi povezani klinični znaki, kot so poliurija (povečana količina urina), polidipsija (povečanje vnosa vode) in izguba telesne mase.
English: ProZinc can only be obtained with a prescription and is available as a suspension for injection (40 IU/ml).
Slovenian: Predpisovanje in izdaja zdravila je le na recept, na voljo pa je v obliki suspenzije za injiciranje (40 i.e./ml).
English: ProZinc is a veterinary medicine used to treat cats and dogs with diabetes.
Slovenian: ProZinc je zdravilo za uporabo v veterinarski medicini, ki se uporablja za zdravljenje sladkorne bolezni pri mačkah in psih.
English: For dogs, if there is insufficient response to treatment after 4 - 6 weeks, the dose and/or frequency can be changed.
Slovenian: Pri psih se lahko odmerek in/ali pogostnost dajanja spremenita, če po štirih do šestih tednih ni dovolj odziva na zdravljenje.
English: The most common side effect during treatment with ProZinc (which may affect more than 1 in 10 animals) is hypoglycaemia (low blood glucose levels) which may result in signs such as hunger, anxiety, unsteady movement, muscle twitching, stumbling or sinking in the rear legs and disorientation.
Slovenian: Najpogostejši neželeni učinek zdravila Procinkov (ki lahko prizadene več kot 1 žival od 10) je hipoglikemija (nizke ravni glukoze v krvi), ki lahko povzroči znake, kot so lakota, anksioznost, nestabilno gibanje, trzanje mišic, spotikanje z zadnjimi nogami ali klecanje zadnjih nog in dezorientacija.
English: For more information about using ProZinc, see the package leaflet or contact your veterinarian or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila ProZinc glejte navodilo za uporabo ali se posvetujte z veterinarjem ali farmacevtom.
English: In an EU field study involving diabetic dogs, ProZinc was as effective as an authorised veterinary insulin, with improvement of at least one blood sugar measurement and at least one of three clinical signs: bodyweight, polyuria and polydipsia.
Slovenian: V terenski študiji v EU, ki je vključevala pse s sladkorno boleznijo, je bilo zdravilo ProZinc enako učinkovito kot odobreni veterinarski insulin, z izboljšanjem vsaj ene meritve krvnega sladkorja in vsaj enega od treh kliničnih znakov: telesne mase, poliurije in polidipsije.
English: What benefits of ProZinc have been shown in studies?
Slovenian: Kakšne koristi zdravila ProZinc so se pokazale v študijah?
English: The active ingredient of ProZinc, human insulin, is produced by a method known as ‘recombinant DNA technology': it is made by yeast cells into which a gene (segment of DNA) has been introduced that makes the yeast cells able to produce insulin.
Slovenian: Učinkovina v zdravilu ProZinc, humani insulin, se proizvaja z metodo, imenovano „tehnologija rekombinantne DNK“, pri kateri ga izdelajo kvasovke, ki so prejele gen (del DNK), kar jim omogoča njegovo tvorjenje.
English: ProZinc works in the same way as naturally produced insulin with a longer duration of action, and helps glucose enter cells from the blood.
Slovenian: Zdravilo ProZinc deluje enako kot naravno tvorjeni insulin z daljšim trajanjem delovanja in pomaga glukozi pri prehajanju iz krvi v celice.
English: A glucose containing solution or gel and/or food is required to be given to the animal immediately.
Slovenian: V tem primeru je treba živali takoj dati glukozno raztopino ali gel in/ali hrano.
English: For a full list of the side effects and restrictions with ProZinc, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila ProZinc glejte navodilo za uporabo.
English: Diabetes is a disease in which the pancreas does not make enough insulin to control the level of blood glucose (sugar) and/or when the body is unable to use insulin effectively.
Slovenian: Sladkorna bolezen je bolezen, pri kateri trebušna slinavka ne proizvaja dovolj insulina za uravnavanje ravni krvnega sladkorja ali pri kateri telo insulina ne more učinkovito izrabiti.
English: If the product is accidentally self-injected, medical advice should be sought immediately and the package leaflet or label shown to the doctor.
Slovenian: V primeru nenamernega samoinjiciranja zdravila nemudoma poiščite zdravniško pomoč in zdravniku pokažite navodilo za uporabo ali nalepko.